PNS52 Valuating Pharmaceutical Innovations Beyond Qalys: A Comprehensive Analysis of VALUE-Based Pricing Models

Abstract

Authors

Z. Ou

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×